FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Susan Welkos

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Virulence

Physiology

Mutation

Co-author Network

Publications

TOP 3
Jared D Heffron; Amy L Jenkins; Laura K Kaatz; Joel Bozue; Christopher K Cote; Susan L Welkos
Phenotypic changes in spores and vegetative cells of Bacillus anthracis associated with BenK.
James M Vergis; Susan L Welkos; Christy L Ventura; Farhang Alem; Joel Bozue; Christopher K Cote; Alison D O'Brien
Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames.
Christopher K Cote; Stephen C Darnell; L Kaatz; Alison D O'Brien; J Reinhardt; P Sanz; S A Tobery; Farhang Alem; A D Bassett; Joel Bozue; Susan L Welkos
Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Susan Welkos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jared D Heffron; Amy L Jenkins; Laura K Kaatz; Joel Bozue; Christopher K Cote; Susan L Welkos
Phenotypic changes in spores and vegetative cells of Bacillus anthracis associated with BenK.
Microbial pathogenesis 2013;57():41-51.
2013: James M Vergis; Susan L Welkos; Christy L Ventura; Farhang Alem; Joel Bozue; Christopher K Cote; Alison D O'Brien
Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames.
Clinical and vaccine immunology : CVI 2013;20(1):56-65.
2012: Christopher K Cote; Stephen C Darnell; L Kaatz; Alison D O'Brien; J Reinhardt; P Sanz; S A Tobery; Farhang Alem; A D Bassett; Joel Bozue; Susan L Welkos
Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.
Journal of medical microbiology 2012;61(Pt 10):1380-92.
2012: Diane Thomas; Susan L Welkos; Christopher Cote; Marianne Manchester; John Naughton; John A T Young
Delayed toxicity associated with soluble anthrax toxin receptor decoy-Ig fusion protein treatment.
PloS one 2012;7(4):e34611.
2012: Mary Kate Hart; George A Saviolakis; Susan L Welkos; Robert V House
Advanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges.
Advances in preventive medicine 2012;2012():731604.
2011: Christopher K Cote; Susan L Welkos; Joel Bozue
Key aspects of the molecular and cellular basis of inhalational anthrax.
Microbes and infection / Institut Pasteur 2011;13(14-15):1146-55.
2011: Susan L Welkos; Joel Bozue; C K Cote; U Hahn; J Jedermann; G Jung; Robert I Lehrer; P Pratikhya; P Ruchala; O Shastak; T Tang; W Beyer
Humanized theta-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infections.
Antimicrobial agents and chemotherapy 2011;55(9):4238-50.
2010: Jill K Terra; Christopher K Cote; Bryan France; Amy L Jenkins; Joel A Bozue; Susan L Welkos; Steven M LeVine; Kenneth A Bradley
Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(1):17-20.
2009: Kari M Severson; Michael Mallozzi; Joel Bozue; Susan L Welkos; Christopher K Cote; Katherine L Knight; Adam Driks
Roles of the Bacillus anthracis spore protein ExsK in exosporium maturation and germination.
Journal of bacteriology 2009;191(24):7587-96.
2009: Amy L Jenkins; Patricia L Worsham; Susan L Welkos
A strategy to verify the absence of the pgm locus in Yersinia pestis strain candidates for select agent exemption.
Journal of microbiological methods 2009;77(3):316-9.
2009: Rebecca Giorno; Michael Mallozzi; Joel Bozue; Krishna-Sulayman Moody; Alex Slack; Dengli Qiu; Rong Wang; Arthur Friedlander; Susan L Welkos; Adam Driks
Localization and assembly of proteins comprising the outer structures of the Bacillus anthracis spore.
Microbiology (Reading, England) 2009;155(Pt 4):1133-45.
2009: Tracy L DiMezzo; Gordon Ruthel; Ernst E Brueggemann; Harry B Hines; Wilson J Ribot; Carol E Chapman; Bradford S Powell; Susan L Welkos
In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis.
PloS one 2009;4(7):e6281.
2008: Michael Mallozzi; Joel Bozue; Rebecca Giorno; Krishna-Sulayman Moody; Alex Slack; Christopher K Cote; Dengli Qiu; Rong Wang; Peter McKenney; Erh-Min Lai; Janine R Maddock; Arthur Friedlander; Susan L Welkos; Patrick Eichenberger; Adam Driks
Characterization of a Bacillus anthracis spore coat-surface protein that influences coat-surface morphology.
FEMS microbiology letters 2008;289(1):110-7.
2008: Narayanan Parthasarathy; S J Peacock; R Saksena; Jeffrey J Adamovicz; S Bavari; Christopher K Cote; David DeShazer; Arthur M Friedlander; H S Heine; P Kováč; Susan L Welkos; V Wuthiekanun; David M Waag
Application of carbohydrate microarray technology for the detection of Burkholderia pseudomallei, Bacillus anthracis and Francisella tularensis antibodies.
Carbohydrate research 2008;343(16):2783-8.
2008: Susan L Welkos; Sarah Norris; Jeffrey J Adamovicz
Modified caspase-3 assay indicates correlation of caspase-3 activity with immunity of nonhuman primates to Yersinia pestis infection.
Clinical and vaccine immunology : CVI 2008;15(7):1134-7.
2008: Christopher K Cote; Tracy L DiMezzo; David J Banks; Bryan France; Kenneth A Bradley; Susan L Welkos
Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection.
Microbes and infection / Institut Pasteur 2008;10(6):613-9.
2008: Christopher K Cote; Joel Bozue; K L Moody; T L DiMezzo; C E Chapman; Susan L Welkos
Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization.
Microbiology (Reading, England) 2008;154(Pt 2):619-32.
2007: Joel Bozue; Krishna L Moody; Christopher K Cote; Bradley G Stiles; Arthur M Friedlander; Susan L Welkos; Martha Hale
Bacillus anthracis spores of the bclA mutant exhibit increased adherence to epithelial cells, fibroblasts, and endothelial cells but not to macrophages.
Infection and immunity 2007;75(9):4498-505.
2007: J Bashaw; S Norris; S Weeks; S Trevino; Jeffrey J Adamovicz; Susan L Welkos
Development of in vitro correlate assays of immunity to infection with Yersinia pestis.
Clinical and vaccine immunology : CVI 2007;14(5):605-16.
2007: Rebecca Giorno; Joel Bozue; Christopher K Cote; Theresa Wenzel; Krishna-Sulayman Moody; Michael Mallozzi; Matthew Ryan; Rong Wang; Ryszard Zielke; Janine R Maddock; Arthur Friedlander; Susan L Welkos; Adam Driks
Morphogenesis of the Bacillus anthracis spore.
Journal of bacteriology 2007;189(3):691-705.
2007: Joel Bozue; Christopher K Cote; K L Moody; Susan L Welkos
Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis.
Infection and immunity 2007;75(1):508-11.
2006: John S Lee; Jennifer L Groebner; Angela G Hadjipanayis; diane negley; Alan L Schmaljohn; Susan L Welkos; Leonard A Smith; Jonathan F Smith
Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.
Vaccine 2006;24(47-48):6886-92.
2006: Christopher K Cote; Nico van Rooijen; Susan L Welkos
Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection.
Infection and immunity 2006;74(1):469-80.
2005: Christopher K Cote; C A Rossi; Angray S Kang; P R Morrow; J S Lee; Susan L Welkos
The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
Microbial pathogenesis 2005;38(5-6):209-25.
2004: Christopher K Cote; Kelly M Rea; Sarah L Norris; Nico van Rooijen; Susan L Welkos
The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores.
Microbial pathogenesis 2004;37(4):169-75.
2004: Susan L Welkos; Christopher K Cote; Kelly M Rea; Paul H Gibbs
A microtiter fluorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies.
Journal of microbiological methods 2004;56(2):253-65.
2004: Susan L Welkos; Gerard P Andrews; Luther E Lindler; NJ Snellings; S D Strachan
Mu dI1(Ap lac) mutagenesis of Yersinia pestis plasmid pFra and identification of temperature-regulated loci associated with virulence.
Plasmid 2004;51(1):1-11.
2003: John S Lee; Angela G Hadjipanayis; Susan L Welkos
Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge.
Infection and immunity 2003;71(3):1491-6.
2002: Susan L Welkos; Arthur Friedlander; S Weeks; S Little; I Mendelson
In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody.
Journal of medical microbiology 2002;51(10):821-31.
2002: Susan L Welkos; M Louise M Pitt; M Martinez; Arthur Friedlander; Peter Vogel; Ralph F Tammariello
Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague.
Vaccine 2002;20(17-18):2206-14.
2002: S Weeks; J Hill; Arthur Friedlander; Susan L Welkos
Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis.
Microbial pathogenesis 2002;32(5):227-37.
2002: Arthur M Friedlander; Susan L Welkos; Bruce E Ivins
Anthrax vaccines.
Current topics in microbiology and immunology 2002;271():33-60.
2001: Susan L Welkos; S Little; Arthur Friedlander; D Fritz; P Fellows
The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
Microbiology (Reading, England) 2001;147(Pt 6):1677-85.
1999: Gerard P Andrews; S T Strachan; GE Benner; A K Sample; GW Anderson; Jeffrey J Adamovicz; Susan L Welkos; Jeffrey K Pullen; Arthur M Friedlander
Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis.
Infection and immunity 1999;67(3):1533-7.
1998: David Heath; GW Anderson; J M Mauro; Susan L Welkos; Gerard P Andrews; Jeffrey J Adamovicz; Arthur M Friedlander
Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine.
Vaccine 1998;16(11-12):1131-7.
1998: GW Anderson; David Heath; Chris R Bolt; Susan L Welkos; Arthur M Friedlander
Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice.
The American journal of tropical medicine and hygiene 1998;58(6):793-9.
1998: W Russell Byrne; Susan L Welkos; M Louise M Pitt; Kelly J Davis; R P Brueckner; J W Ezzell; G O Nelson; J R Vaccaro; L C Battersby; Arthur M Friedlander
Antibiotic treatment of experimental pneumonic plague in mice.
Antimicrobial agents and chemotherapy 1998;42(3):675-81.
1998: Susan L Welkos; Arthur Friedlander; D McDowell; J Weeks; S Tobery
V antigen of Yersinia pestis inhibits neutrophil chemotaxis.
Microbial pathogenesis 1998;24(3):185-96.
1998: Jeffrey K Pullen; GW Anderson; Susan L Welkos; Arthur M Friedlander
Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopes.
Infection and immunity 1998;66(2):521-7.
1997: Susan L Welkos; Arthur M Friedlander; Kelly J Davis
Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain C092.
Microbial pathogenesis 1997;23(4):211-23.
1997: Kelly J Davis; Peter Vogel; David Fritz; KE Steele; M Louise M Pitt; Susan L Welkos; Arthur M Friedlander; W Russell Byrne
Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice.
Archives of pathology & laboratory medicine 1997;121(8):865-8.
1997: GW Anderson; Patricia Worsham; Chris R Bolt; Gerard P Andrews; Susan L Welkos; Arthur M Friedlander; J P Burans
Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis.
The American journal of tropical medicine and hygiene 1997;56(4):471-3.
1996: GW Anderson; Sophie E C Leary; E Diane Williamson; Richard Titball; Susan L Welkos; P L Worsham; Arthur M Friedlander
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.
Infection and immunity 1996;64(11):4580-5.
1996: Gerard P Andrews; David Heath; GW Anderson; Susan L Welkos; Arthur M Friedlander
Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge.
Infection and immunity 1996;64(6):2180-7.
1996: Kelly J Davis; D L Fritz; M Louise M Pitt; Susan L Welkos; P L Worsham; Arthur M Friedlander
Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops).
Archives of pathology & laboratory medicine 1996;120(2):156-63.
1995: Arthur M Friedlander; Susan L Welkos; P L Worsham; Gerard P Andrews; David Heath; GW Anderson; M Louise M Pitt; J Estep; K Davis
Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21 Suppl 2():S178-81.
1995: R Marrero; Susan L Welkos
The transformation frequency of plasmids into Bacillus anthracis is affected by adenine methylation.
Gene 1995;152(1):75-8.
1995: N J Vietri; R Marrero; T A Hoover; Susan L Welkos
Identification and characterization of a trans-activator involved in the regulation of encapsulation by Bacillus anthracis.
Gene 1995;152(1):1-9.
1995: P L Worsham; M P Stein; Susan L Welkos
Construction of defined F1 negative mutants of virulent Yersinia pestis.
Contributions to microbiology and immunology 1995;13():325-8.
1995: Susan L Welkos; K M Davis; L M Pitt; P L Worsham; A M Freidlander
Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis.
Contributions to microbiology and immunology 1995;13():299-305.
1994: Susan L Welkos; A O'Brien
Determination of median lethal and infectious doses in animal model systems.
Methods in enzymology 1994;235():29-39.
1993: Arthur M Friedlander; Susan L Welkos; M Louise M Pitt; J W Ezzell; P L Worsham; K J Rose; Bruce E Ivins; J R Lowe; G B Howe; P Mikesell
Postexposure prophylaxis against experimental inhalation anthrax.
The Journal of infectious diseases 1993;167(5):1239-43.
1993: Susan L Welkos; N J Vietri; P H Gibbs
Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pX02 and chromosome in strain-dependent virulence.
Microbial pathogenesis 1993;14(5):381-8.
1992: Bruce E Ivins; Susan L Welkos; Stephen F Little; M H Crumrine; G O Nelson
Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants.
Infection and immunity 1992;60(2):662-8.
1991: L C Iacono-Connors; Susan L Welkos; Bruce E Ivins; J M Dalrymple
Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals.
Infection and immunity 1991;59(6):1961-5.
1991: Susan L Welkos
Plasmid-associated virulence factors of non-toxigenic (pX01-) Bacillus anthracis.
Microbial pathogenesis 1991;10(3):183-98.
1990: Bruce E Ivins; Susan L Welkos; G B Knudson; Stephen F Little
Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.
Infection and immunity 1990;58(2):303-8.
1989: Susan L Welkos; R W Trotter; D M Becker; G O Nelson
Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice.
Microbial pathogenesis 1989;7(1):15-35.
1988: Susan L Welkos; J R Lowe; F Eden-McCutchan; M Vodkin; Stephen H Leppla; J J Schmidt
Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis.
Gene 1988;69(2):287-300.
1988: Susan L Welkos; Arthur M Friedlander
Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice.
Microbial pathogenesis 1988;5(2):127-39.
1988: Bruce E Ivins; Susan L Welkos
Recent advances in the development of an improved, human anthrax vaccine.
European journal of epidemiology 1988;4(1):12-9.
1988: Susan L Welkos; Arthur M Friedlander
Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.
Microbial pathogenesis 1988;4(1):53-69.
1988: Bruce E Ivins; Susan L Welkos; G B Knudson; D J Leblanc
Transposon Tn916 mutagenesis in Bacillus anthracis.
Infection and immunity 1988;56(1):176-81.
1986: Bruce E Ivins; Susan L Welkos
Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis.
Infection and immunity 1986;54(2):537-42.
1986: Susan L Welkos; T J Keener; P H Gibbs
Differences in susceptibility of inbred mice to Bacillus anthracis.
Infection and immunity 1986;51(3):795-800.